VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript
Vascular Biogenics Ltd. (VBLT) Q4 2021 Earnings Conference Call March 22, 2022 8:30 a.m. ET Company Participants Dror Harats - CEO Sam Backenroth - CFO Dan Ferry - LifeSci Advisors, IR Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Susan Chor - Oppenheimer & Co. Swayampakula Ramakanth - H.C. Wainwright Soumit Roy - JonesTrading Jonathan Kreizman - Valore Research Presentation Operator Greetings, and welcome to the VBL Therapeutics Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like turn the conference over to Dan Ferry of LifeSci Advisors. Thank you. You may begin. Dan Ferry Thank you, Operator. Good morning, everyone, and thank you for joining the VBL Therapeutics full year quarter 2021 financial results and corporate update call. Joining me on
For further details see:
Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript